Consistent finding was also observed in another study, where JNK expression was markedly higher in the advanced stages of NPC (III and IV) (89.2% ± 11.7%) compared to individuals in the early stages (I and II) (58.90% ± 4.90%) [260]. Here, MAPK8 is linked to nasopharyngeal carcinoma.